Incyte (INCY) EBIT (2010 - 2026)
Incyte's EBIT came in at $697.9 million for Q2 2026, up 31.6% from $530.31 million a year earlier and up 131.8% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) EBIT (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Incyte reported EBIT of $1.78 billion, up 50.3% year-over-year; for FY2025, it was $1.51 billion.
- Going back by year, EBIT was $61.37 million in FY2024 (-90.1%), $620.53 million in FY2023 (+7.1%), $579.44 million in FY2022 (-1.1%) and $585.78 million in FY2021.
- The Q2 2026 figure represents the highest quarterly EBIT in data going back to Q1 2010.
- Year-over-year, EBIT has increased for four consecutive quarters, with growth averaging 63.7% over the last seven quarters.
- The fastest year-over-year change in EBIT over five years came in Q1 2024 (growth of 271.0%), and the weakest in Q1 2023 (a decline of 78.7%).
- Business Quant data shows INCY's EBIT at $301.12 million (Q1 2026), $335.86 million (Q4 2025) and $443.52 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Incyte | 25.09 Bn | 10.02 Bn | 1.57 Bn | 697.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 697.90 Mn |
| Mar 31, 2026 | 301.12 Mn |
| Dec 31, 2025 | 335.86 Mn |
| Sep 30, 2025 | 443.52 Mn |
| Jun 30, 2025 | 530.31 Mn |
| Mar 31, 2025 | 205.17 Mn |
| Dec 31, 2024 | 301.51 Mn |
| Sep 30, 2024 | 146.09 Mn |
| Jun 30, 2024 | -478.13 Mn |
| Mar 31, 2024 | 91.90 Mn |
| Dec 31, 2023 | 187.27 Mn |
| Sep 30, 2023 | 214.71 Mn |
| Jun 30, 2023 | 193.78 Mn |
| Mar 31, 2023 | 24.77 Mn |
| Dec 31, 2022 | 70.09 Mn |
| Sep 30, 2022 | 138.38 Mn |
| Jun 30, 2022 | 254.43 Mn |
| Mar 31, 2022 | 116.54 Mn |
| Dec 31, 2021 | 110.73 Mn |
| Sep 30, 2021 | 235.41 Mn |
API Access
Incyte EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();